MorphoSys AG (MOR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MOR.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
MOR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The percent of analysts bearish on the stock of MOR is less than just about 100% of all US stocks.
- The number of analysts covering the stock of MOR is higher than 93.6% of stocks in the mid market cap category.
- MorphoSys AG's upside potential (average analyst target price relative to current price) is greater than 89.28% of stocks in the mid market cap category.
- MorphoSys AG's variance in analysts' estimates is less than 22.64% of all US stocks.
- The percentage of analysts bullish on the stock of MOR is higher than 71.56% of stocks in the mid market cap category.
- MOR has a higher average analyst price target than 71.05% of Pharmaceutical Products stocks.
- MorphoSys AG's change in bullishness amongst analysts is less than just about 100% of all US stocks.
What is the outlook for MOR? Use POWR Ratings for clearer insight into price direction.